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In recent studies  (1-3)  it has been demonstrated  that  the passive  transfer of im- 
rnunocompetent  allogeneic  lymphoid  cells  to  guinea  pigs  previously  primed  with 
2,4-dinitrophenyl-ovalbumin  (DNP-OVA)  1  results  in  the  increased  synthesis  of 
anti-DNP and anti-OVA antibodies in the absence of further antigenic challenge, and 
markedly  enhances anti-DNP  responses  to  an appropriately  timed challenge  with 
DNP  coupled  to  an  unrelated  carrier,  bovine  gamma  globulin  (BGG).  This  phe- 
nomenon has  been  termed  the  "allogeneic effect"  and  has  several salient  features. 
First,  the  phenomenon reflects  and  requires  the  development of a  transient  graft- 
versus-host (GVtt) reaction in the lymphoid organs of the primed host (1).  The exist- 
ence of a concomitant host rejection reaction is not only not required, but appears to 
play little  if any role  (3).  Secondly, the lymphoid cells  of the host must be primed 
before the administration of allogeneic cells.  Numerous attempts  to demonstrate an 
enhanced primary response by the prior administration of allogeneic cells have failed, 
and,  indeed,  the primary response  is  usually suppressed  under  these  circumstances 
(1-3a).  Finally,  the allogeneic effect has been shown to replace the requirement  for 
carrier-specific helper T  cells in the development of hapten-specific anamnestic anti- 
body responses manifested by the primed lymphoid cells of the host (2). 
The studies  presented  in this  and  the accompanying paper  (4)  were under- 
taken  in  inbred  mice  to  elucidate  further  the  phenomenon  of  the  allogeneic 
effect,  in  that,  as  a  model,  the mouse  provides  greater  flexibility  in manipu- 
lating  cell  populations  and histocompatibility  differences.  In  the  experiments 
described here,  we show that:  (a)  the general  features  of the allogeneic effect 
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in  mice  parallel,  in  general,  those  demonstrated  in  the  guinea  pig  and  are 
critically  related  to  factors  such  as  time  interval  between  cell  transfer  and 
challenge,  dose  of  allogeneic cells employed  and  route  of  administration,  and 
magnitude  of  histocompatibility  differences  between  donor  and  host;  (b)  the 
aUogeneic  effect in  mice,  as  in  guinea  pigs  (1-3),  effectively replaces  the  re- 
quirement for carrier-specific helper T  cells; and primed B  lymphocytes which 
are  not  integral  participants  in  the  active  GVH  reaction,  but  rather  are  by- 
standers  to such  a  reaction,  do not appear  to develop enhanced  antibody  pro- 
duction  as a  result  of the  allogeneic effect. 
Materials and Methods 
Proteins and Chemical Reagents.--Hen  ovalbumin  (OVA)  5X  recrystallized and  bovine 
gamma  globulin  (BGG)  were  obtained  from Pentex Biochemical, Kankakee,  Ill.  Keyhole 
limpet hemocyanin (KLH) was purchased from Pacific Biomarine Supply Co., Venice, Calif. 
Taka-amylase A (TAA), a purified and recrystallized amylase from the bacterium Aspergillus 
oryzae, was kindly provided by Dr. T. Hamaoka in our laboratory.  The copolymer of D-glu- 
tamic acid and D-lysine  (D-GL) was obtained from Pilot Chemicals, Inc., Watertown,  Mass. 
The isomer had an average molecular weight of 115,000 and a ratio of G:L of 60:40.  All other 
chemical reagents used  were, in general,  identical with those described  in previous related 
studies (5). 
Hapten-Carrier Conjugates.--The following 2,4-dinitrophenyl (DNP)  conjugates were pre- 
pared as previously described  (5,  6): DNPg-KLH,  DNPa2-BGG,  DNPs-OVA,  and  DNPg- 
TAA. The preparation  of  DNPaT-D-GL has been described in detail elsewhere (2). Subscripts 
refer to the average number of moles of DNP per mole of carrier. 
Immunizations and Cell Transfers.--Mice of the inbred lines BALB/c, A/J, and (BALB/c X 
A/J)F1 hybrids (CAFI) were obtained from Jackson Laboratory, Bar Harbor, Maine. BALB/c 
mice were also obtained from West Seneca Laboratories, Buffalo, N.Y. All mice were used at 
8-12 wk of age.  The general scheme of the basic experimental protocol is outlined diagram- 
matically  in  Fig.  1.  In general,  primary  immunization with hapten-carrier  conjugates was 
carried out with 100 #g of aqueous DNP-KLH plus  l0  s Bordetdla pertussis organisms  (Eli 
Lilly & Co., Indianapolis, Ind.)  intraperitoneally.  2 wk later, DNP-KLH-primed mice were 
injected  intraperitoneally  or  intravenously  with  varying  numbers  of  allogeneic  or  semi- 
allogeneic splenic lymphoid cells. Such transferred cells were obtained from single  cell suspen- 
sions,  prepared and washed in minimal essential medium (Eagle), from spleens  of nonimmune 
donor mice. At varying intervals after cell transfer, recipients and control mice which had not 
received cell transfers were secondarily challenged with a DNP-carrier conjugate administered 
in  aqueous form intraperitoneally.  All animals were bled just before the challenge  (day 0) 
and 7 (day 7) days later, and anti-DNP antibody determinations were performed as described 
below. 
Measurement of Anti-DNP Antibodies.--Serum anti-DNP antibody levels were determined 
by a modified Farr technique (7, 8) using DNp-aH-~-amino-N-caproic acid (5). Using standard 
curves constructed for individual mouse strains in a manner identical to that described pre- 
viously for inbred guinea pigs (5), percentage of binding was converted into amount of anti- 
DNP antibody in micrograms per milliliter of serum. 
Statistical Analysis.--Serum  antibody levels were logarithmically transformed and means 
and standard  errors calculated. Group comparisons were made employing Student's t test. In 
those mice in which no specific  antigen binding could be detected in  the serum, a  value of 
0.10/ug/ml was arbitrarily assigned to allow logarithmic transformation of the data. DAVID  P.  OSBORNE,  JR.  AND  DAVID  H.  KATZ  441 
NORMAL  ALLOGENEIC 
SPLEEN  CELLS 
I'V" l 
J 
BOOST  I,P.  I.P.  BLEED  DayO  BLEED  Day7 
I  I 
J, 
ASSAY 
SERUM  ANT~-ONP  A.T~BOBY 
FIc.  1.  Model I: transfer of allogeneic lymphoid cells into primed host. Experimental 
protocol for the elicitation of the allogeneic effect in inbred mice. See Materials and Methods 
for explanation. 
RESULTS 
Elicita$ion of the Allegeneic Effect in Inbred Mice.--Groups of CAF1 mice, primed 2 wk 
previously with DNP-KLH, were injected intraperitoneally with 25 or 50 X  106 spleen cells 
from nonimmunized parental A strain donors. 6 days later,  these recipient mice and groups 
of similarly primed control mice which had received no allogeneic cell transfer were subjected 
to secondary challenge intraperitoneally with either 100 #g of DNP-KLH or varying doses 
(10, 50, or 100/zg) of the heterologous conjugate, DNP-BGG. 
As illustrated in Fig. 2 and Table I, all mice challenged with the homologous 
conjugate,  DNP-KLH,  displayed  comparable secondary  anti-DNP  antibody 
responses  irrespective  of  whether  or  not  they  had  received  parental  donor 
cells.  This observation, which was consistent in many such experiments, prob- 
ably reflects  the  essentially maximal stimulation  induced  by the  homologous 
DNP  carrier.  On  the  other  hand,  a  striking  contrast  is  evident  among  the 
groups  of  mice  subjected  to  secondary  challenge  with  DNP-BGG.  Hence, 
whereas  comparatively little  or  no  secondary  anti-DNP  response  to  DNP- 
BGG was obtained in  control animals,  a  very clear allogeneic effect reflected 
by,  in  some instances,  markedly enhanced  antibody responses was  observed 
in  recipients of parental  spleen  cells.  Elicitation  of the  effect, and  its magni- 
tude, was related to the dose of DNP-BGG administered as well as the number 
of  cells  transferred.  Thus,  the  most  striking  enhancement  occurred  in  the 
recipients  of 50  >(  106  cells  that  were  challenged with  50 #g of DNP-BGG, 
conditions  which  resulted  in  a  secondary anti-DNP  response of even greater 
magnitude  than  that elicited with DNP-KLH. A  significant allogeneic effect, 442  ALLOGENEIC EFFECT IN  MICE 
though lesser in magnitude, was also obtained in recipients of 25  X  106  ceils 
challenged with 50 ~g of DNP-BGG and in recipients of both cell doses chal- 
lenged with  100  ~g  of DNP-BGG. Animals challenged with  10  t~g  of  DNP- 
BGG,  on  the  other  hand,  failed to  display significantly enhanced secondary 
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FIG.  2.  Elicitation  of  the  allogeneic effect in DNP-KLH-primed  CAF1 recipients  of 
parental A strain lymphoid cells. CAF1 mice, primed 2 wk previously with  100/zg DNP- 
KLH plus 108 B. pertussis, were injected intraperitoneally with 25 or 50 X  106 spleen cells 
from nonimmunized A strain donor mice. Control DNP-KLH-primed CAF1 mice (open bars) 
did not receive allogeneic  cells. 6 days after cell transfer groups of five mice received secondary 
challenge intraperitoneally  with  either  100 #g of DNP-KLH or varying doses (10, 50, or 
100 #g) of DNP-BGG. The increase in geometric mean serum anti-DNP antibody levels from 
just before secondary challenge to 7 days later is illustrated for the respective groups. 
anti-DNP antibody responses regardless of the dose of parental cells injected. 
Comparable  results  were  obtained  in  studies  not  shown  in  which  parental 
BALB/c cells were transferred to primed CAF1 mice. 
Effect of Varying the Rout* of Administration  of AUogeneic Lymphoid Cells.--2 wk after pri- 
mary immunization with DNP-KLH, groups of CAF1 and BALB/c mice were injected either 
intravenously or intraperitoneally with varying numbers of spleen cells from nonimmunized A 
donors. 6 days later, recipients of allogeneic cells and similarly primed control mice of each DAVID  P.  OSBORNE~  JR.  AND  DAVID  H.  KATZ  443 
strain which had received no cell transfer were challenged with 100 #g of DNP-BGG intra- 
peritoneally. 
The  results  are  summarized  in  Table  II.  Both  recipient  strains  displayed 
enhanced  secondary  anti-DNP  antibody  responses  as  a  result  of  allogeneic 
TABLE  I 
Elicitation  of the Allogeneic Effect in DNP-KLH-Primed CAF1 Recipients  of 
Parental A  Strain Lymphoid Cells 
Protocol*  Anti-DNP antibody (ug/ml):~ 
Group  No. of allogeneic cells  Secondary  challenge 
transferred  Day 0  Day 7  Boost 
A  None  100#g  59.7  1858.0  1798.3 
B  25  X  106  DNP-KLH  58.0  1747.0  1689.0 
C  50  X  106  64.0  2448.0  2384.0 
D  None  10#g  110.5  279.3  168.8 
E  25  X  106  DNP-BGG  25.0  532.0  507.0 
F  50  X  106  46.9  403.6  356.7 
G  None  50#g  23.8  117.4  93.6 
H  25  X  106  DNP-BGG  53.8  942.0  888.2 
I  50  X  106  84.0  3725.0  3641.0 
J  None  100 #g  56.6  363.9  307.3 
K  25  X  106  DNP-BGG  21.0  1287.0  1266.0 
L  50  X  106  45.6  1982.4  1936.8 
* CAF1  mice, primed 2  wk  earlier with  100#g  DNP-KLH  plus  108 B.  pertussis,  were 
injected intraperitoneally with 25 or 50 X  106 spleen cells from normal A strain donor mice. 
Control DNP-KLH-primed  CAF1 mice received no allogeneic cell transfer. 6 days after cell 
transfer,  groups  of  mice  received  secondary  challenge with  a  DNP-carrier  conjugate  as 
indicated above. 
:~ The data are expressed as geometric means of groups of five mice. Boost represents the 
increase in mean antibody levels from the day of secondary challenge (day 0) to 7 days later 
(day 7). A comparison of the geometric mean boost values gave the following results: com- 
parison of group A with groups B and C yielded a P  value of 0.80 >  P  >  0.70. Comparison 
of group D with groups E  and F yielded P  values of 0.10 >  P  >  0.05 and 0.20 >  P  >  0.10, 
respectively. Comparison of group G with groups H  and I  yielded P  values of 0.02  >  P  > 
0.01  and 0.001  >  P,  respectively. Comparison of group J  with groups K  and L  yielded P 
values of 0.025 >  P  >  0.02 and 0.02 >  P  >  0.01, respectively. 
cell  transfer,  although  the  optimal  conditions  for  obtaining  the  effect  clearly 
differed  between  them.  Thus,  CAF1  mice  manifested  enhanced  anti-DNP 
antibody  responses  after  transfer of allogeneic cells either intraperitoneally or 
intravenously, the latter route being most effective. BALB/c  recipients, on the 
other  hand,  displayed  enhanced  secondary  responses  only  when  allogeneic 444  ALLOGENEIC  EFFECT  IN  MICE 
cells  were  injected  intravenously;  cells  administered  intraperitoneally  were 
ineffective at the cell doses employed. 
The  magnitude  of  the  allogeneic  effect was  also  related  to  the  numbers  of 
TABLE II 
The Effect of Varying the Route of Administration of Allogeneic Lymphoid Cells on the Elicitation 
of the Allogenelc Effect in DNP-KLH-Prfmed  CAF1 and BALB/c Mice 
Protocol*  Anti-DNP Antibody (~g/ml) ;t 
No. of allogeneic A/J 
Recipient strain  Group  cells transferred  Secondary challenge  Day 0  Day 7  Boost 
and route 
DNP-KLH-primed  A  None  12.2  97.0  84.8 
CAFt  B  5  X  104 i.p.  100 #g  13.4  144.9  131.5 
C  25  X  106 i.p.  DNP-BGG  13.4  224.0  210.6 
D  5  X  106i.v.  12.1  150.6  138.5 
E  25  X  106 i.v.  42.2  362.0  319.8 
DNP-KLH-primed  F  None  3.1  10.8  7.7 
BALB/c  G  5  X  106i.p.  100#g  3.4  3.2  --0.2 
H  25  X  106i.p.  DNP-BGG  5.4  3.7  --1.7 
I  5  X  106i.v.  4.1  16.3  12.2 
J  25  X  104 i.v.  5.3  33.9  28.6 
* CAF1 and  BALB/c mice,  primed  2 wk  earlier with DNP-KLH,  were injected intra- 
peritoneally or intravenously with 5 or 25 X  106 spleen cells from normal A strain donor mice. 
Control DNP-KLtt-primed  CAF1 and  BALB/c mice received no allogeneic cell transfer.  6 
days after cell transfer all mice were boosted with 100 #g of DNP-BGG. 
:~ The data are expressed  as  geometric means of groups of four mice. Boost represents the 
increase in mean antibody levels from the day of secondary challenge (day 0)  to 7 days later 
(day 7). A comparison of geometric mean antibody levels on day 7 of group A with its respec- 
tive experimental groups yielded P  values of: 
(a)  group A with group B, 0.80  >  P  >  0.70, 
(b)  group A with group C, 0.20  >  P  >  0.10, 
(c)  group A with group D, 0.30  >  P  >  0.20, 
(d)  group A with group E, 0.01  >  P  >  0.005. 
A  comparison of geometric mean  antibody levels on  day  7 of group  F  with its  respective 
experimental groups yielded P  values of: 
(a)  group F  with group G, 0.40  >  P  >  0.30, 
(b)  group F with group H, 0.05  >  P  >  0.025, 
(c)  group F with group I, 0.20  >  P  >  0.10, 
(d)  group F with group J, 0.10  >  P  >  0.05. 
donor  cells transferred.  In  the  present  experiment  the  dose  of  25  X  106  allo- 
geneic  cells was  considerably  more  effective than  5  X  106  cells in  both  CAF1 
and  BALB/c  recipients.  On  the other hand,  doses higher than  25  X  10  ~ cells, 
particularly  when  the  cells  are  administered  intravenously,  usually  result  in 
suppression  of  antibody  production  (unpublished  observations).  Based  on 
these  observations,  subsequent  experiments  were  performed  utilizing  the 
25  X  106  cell dose  and  the  intravenous  route  of administration. DAVID  P.  OSBORNE,  JR.  AND  DAVID  H.  KATZ  445 
Effect  of  Varying  the  Time  Interval  Between  Allogeneic  Cell  Transfer  and 
Secondary  Challenge.--In  the  preceding  experiments,  an  interval  of  6  days 
between  allogeneic  cell  transfer  and  secondary  challenge  was  employed  since 
this had  been found  to be the optimal  time interval  in the guinea pig system. 
The present  experiment was  carried out to elucidate  the optimal  time interval 
in the mouse system. 
DNP-KLH-primed CAFI mice were injected intravenously with  25  )<  106  parental  A 
strain lymphoid cells. At varying intervals after cell transfer, recipient mice and primed con- 
trol animals which had received no allogeneic cells were challenged with either 10 #g of DNP- 
KLH or 50 #g of DNP-BGG intraperitoneally. 
The  results  are  summarized  in  Table  III.  When  secondary  challenge  was 
made  with  the  homologous  antigen,  DNP-KLH,  control  mice  as well as  allo- 
TABLE III 
Effect o/ Varying the Time Interval Between TransJer of Allogeneic Lymphoid Cells and Secondary 
Challenge on the Magnitude of the Allogeneic Effect in CAF1 Mice 
Protocol*  Anti-DNP antibody ~g/ml)* 
No. of allogeneic 
Group  A/J cells  Time interval  Secondary  challenge  Day 0  Day 7  Boost 
transferred 
A  None  1 day  50 #g DNP-BGG  139.0  208.0  69.0 
B  25  X  106  46.5  1049.0  1002.5 
C  None  2 days  30.1  161.0  130.9 
D  25  X  l0  s  46.5  3210.0  3163.5 
E  None  3 days  13.0  212.0  199.0 
F  25  X  106  25.0  818.0  793.0 
G  None  1 day  10 #g DNP-KLH  40.8  2242.0  2201.2 
H  25  X  106  55.0  2415.0  2360.0 
I  None  2 days  24.8  1366.0  1341.2 
J  25  X  106  39.0  5230.0  5191.0 
K  None  3 days  62.0  4029.0  3967.0 
L  25  X  106  108.0  3500.0  3392.0 
* CAF1 mice,  primed  2  wk  earlier with  DNP-KLH,  were  injected  intravenously with 
25  X  10  s spleen cells from normal A strain donor mice. Control DNP-KLH-primed CAF1 
mice received no allogeneic cell transfer. At varying time intervals after cell transfer, groups 
of control and  experimental mice received secondary  challenge with  either DNP-BGG  or 
DNP-KLH. 
:~ The data are expressed as geometric means of groups of four mice. Boost represents the 
increase in mean antibody level from the day of secondary challenge (day 0)  to 7 days later 
(day 7). A comparison of geometric mean boost values gave the following results: 
(a)  comparison of group A with group B yielded 0.20  >  P  >  0.10, 
(b)  comparison of group C with group D yielded 0.001  >  P, 
(c)  comparison of group E with group F  yielded 0.10  >  P  >  0.05, 
(d)  comparison of group G with group H yielded 0.90  >  P  >  0.80, 
(e)  comparison of group I  with group J  yielded 0.20  >  P  >  0.10, 
(f)  comparison of group K with group L yielded 0.60  >  P  >  0.50. 446  ALLOGENEIC  EFFECT  IN  MICE 
geneic cell  recipients displayed,  as  expected, very good secondary anti-DNP 
antibody responses.  The magnitudes  of such  secondary responses were  com- 
parable between the control and experimental groups at the 1- and 3-day in- 
tervals; however, when DNP-KLH was administered 2 days after cell transfer, 
recipients of allogeneic cells displayed considerably higher secondary responses 
than corresponding controls. The response to the heterologous antigen, DNP- 
BGG,  offers a  striking  contrast  in  that  allogeneic cell  recipients manifested 
markedly enhanced anti-DNP antibody production, as compared with controls, 
at  all time intervals employed. The magnitude of the allogeneic effect is,  in- 
deed,  related to  the  time interval between  transfer and  secondary challenge 
as evidenced by the considerably higher response observed in mice challenged 
2 days after transfer. It is noteworthy that additional studies indicate that at 
intervals of 6 days or longer the effect of allogeneic cell transfer tends to dimin- 
ish rather than enhance anti-DNP antibody production. 
Enhancement of Secondary Responses to DNP Conjugates of Various Hetero- 
logous Carrier Molecules.--The  capacity of a  transient GVH reaction to aug- 
ment secondary anti-DNP antibody responses to a heterologous carrier-DNP 
conjugate  indicates  that  the  allogeneic  effect  replaces  the  requirement  for 
carrier-specific helper cells  to participate in such reactions (1-3). Indeed,  this 
has been amply demonstrated in previous studies in inbred guinea pigs (2). The 
present experiment was designed to confirm this critical point in mice utilizing 
several different carrier molecules known to vary considerably in immunogenic 
strength. Thus, BGG and OVA were employed as carriers of moderate to high 
immunogenicity while TAA was employed as a carrier of relatively low immuno- 
genicity in these mice. The copol)Tner of I)-GL was employed as a nonimmuno- 
genic carrier molecule based on previous observations with  this  substance  in 
guinea pigs  (2)  and mice (unpublished observations). Indeed, under ordinary 
circumstances of administration to either nonimmune or DNP-primed guinea 
pigs  (2)  or mice (unpublished observations),  the DNP  conjugate of I)-GL in- 
duces a profound state of DNP-specific B cell tolerance. 
CAF1 mice, primed 2 wk previously with DNP-KLH, were injected intravenously with 
25 X  106 lymphoid cells from nonimmune  A strain donors. 2 days after cell transfer, groups 
of recipient mice and similarly primed control animals which received  no allogeneic  cells were 
challenged with either the homologous conjugate, DNP-KLH  (10/zg), or with one of the 
heterologous  carrier conjugates intraperitoneally. 
The results are summarized in Table IV and depicted graphically in Fig. 3. 
Secondary challenge with DNP-KLH elicited, as expected, very good anti-DNP 
antibody responses in control mice. As in the preceding experiment, the secon- 
dary  responses  to  DNP-KLH  of  allogeneic  cell  recipients  were  enhanced 
roughly fourfold over controls. However, even more striking effects were ob- 
tained  in  allogeneic cell  recipients challenged with heterologous carrier  con- 
jugates.  Thus,  recipients  of  allogeneic  cells  manifested  markedly  enhanced 
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TABLE IV 
Enhancement of Secondary Responses of DNP-KLH-Primed CAF1 Mice to DNP Conjugates of 
Various Heterologous Carrier Molecules after Transfer of Parental A  Strain 
Lymphoid  Cells 
Protocol*  Anti-DNP antibody (~g/ml)$ 
Group  No. of allogeneic  Secondary challenge  Day 0  Day 7  Boost  cells transfered 
A  None  10 #g  11.9  559.3  547.4 
B  25  X  106  DNP-KLH  24.6  2211.5  2186.9 
C  None  50/zg  24.2  40.7  16.5 
D  25  X  106  DNP-BGG  17.3  106.4  89.1 
E  None  50 #g  14.0  14.8  0.8 
F  25  X  106  DNP-OVA  24.8  124.8  100.0 
G  None  50 #g  8.2  8.0  -0.2 
H  25  X  106  DNP-TAA  6.0  100.9  94.9 
I  None  10 #g  12.9  0.2  -- 12.7 
J  25  X  106  DNP-D-GL  12.1  158.9  146.8 
K  None  1.0 #g  20.2  12.4  --7.8 
L  25  X  106  DNP-D-GL  14.4  93.5  79.1 
* CAF1  mice,  primed  2  wk  earlier with  DNP-KLH,  were injected  intravenously with 
25  X  10 a spleen cells from normal A strain donor mice. Control DNP-KLH-primed CAF1 
mice received no  allogeneic cell transfer.  2  days  after cell transfer,  groups  of control and 
experimental mice received secondary challenge with a  DNP-carrier conjugate as indicated 
above. 
:~ The data are expressed as geometric means of groups of four mice. Boost represents the 
increase in mean antibody levels from the day of secondary challenge  (day 0) to 7 days later 
(day 7).  A comparison of geometric mean boost values  of the respective  groups with their 
controls yielded P  values of: 
(a)  group A with group B, 0.40  >  P  >  0.30, 
(b)  group C with group D, 0.40  >  P  >  0.30, 
(c)  group E with group F, 0.025  >  P  >  0.02, 
(d)  group G with group H, 0.10  >  P  >  0.05, 
(e)  group I with group J, 0.001  >  P, 
(f)  group K  with group L, 0.005  >  P  >  0.001. 
either DNP-BGG,  DNP-OVA,  or DNP-TAA.  Most impressive and  significant 
were the responses of allogeneic cell recipients to both  10- and  1-#g doses of the 
conjugate,  DNP-D-GL. Hence,  the capacity  to elicit enhanced  secondary  anti- 
DNP  responses  with  heterologous  carrier  conjugates  of  varying  degrees  of 
immunogenicity,  and  particularly  with  a  normally  tolerogenic  substance,  as 
a  result  of  the  allogeneic  effect  provides  compelling  evidence  that  this  phe- 
nomenon replaces the function of carrier-specific helper T  cells. 
Failure to Observe the Effect When Primed B  cells are Bystanders  to the Allo- 448  ALLOGENEIC  EFFECT  IN  MICE 
geneic Cell Interaction.--In  the initial studies of the allogeneic effect in guinea 
pigs it was  clearly demonstrated that mediation of the phenomenon required 
the existence of an active GVH reaction (1). Existence of a host rejection re- 
sponse alone was not sufficient, irrespective of its magnitude (1). Moreover, a 
host  rejection response is  not even required as  evidenced by the capacity to 
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Enhancement of secondary responses of DNP-KLH-primed CAFz  mice to DNP 
conjugates of various heterologous carrier molecules after transfer of parental A strain lymph- 
oid cells. CAF1 mice, primed 2 wk previously with 100 #g of DNP-KLH plus l0  s B.  pertussls, 
were  injected  intravenously with  25  X  106  spleen cells from  normal  A  strain  donor  mice 
(shaded bars). Control DNP-KLH-primed CAF1 mice (open bars)  did not receive allogeneic 
cells.  2  days after cell transfer, groups of control and experimental mice received secondary 
challenge with a  DNP-carrier  conjugate as indicated above. The increase in geometric mean 
serum  anti-DNP  antibody  levels  from  just  before  secondary  challenge  to  7  days  later  is 
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elicit  the phenomenon  in  primed  F~ hybrid  recipients  of parental  donor  cells, 
as shown previously in guinea pigs  (3)  and  in the present studies in mice. This 
point  suggests  that  more  than  antigenic  stimulation,  per  se,  by  histocom- 
patibility  antigens  nmst  take  place  for  the  allogeneic  effect  to  be  expressed. 
TABLE V 
Failure  to  Observe the  Allogeneic  Effect  When DNP-KLH-Primed  BALB/c  B  Lymphocyles 
Are Not an Integral  Participant in the Allogeneic  Cell Interaction 
Protocol*  Anti-DNP antibody 
0zg/ml)  :~ 
Irradiated recipient 
Group  Secondary challenge  of DNP-KLH-primed  Day 8 after transfer 
BALB/c cells 
A  None  6.8 
B  I0 #g  DNP-KLH  BALB/c  410.6 
C  100  #g  DNP-KLH  508.5 
D  100 #g  DNP-BGG  5.6 
E  None  2.4 
F  10 #g  DNP-KLH  A/J  301.7 
G  100 #g  DNP-KLH  358.4 
H  100 #g  DNP-BGG  0.2 
* 25 X  106 BALB/c spleen cells, primed 2 wk earlier with 100 #g DNP-KLH in complete 
Freund's  adjuvant,  were injected intraperitoneally into irradiated  syngeneic BALB/c and 
allogeneic A/J recipients. The same day groups of mice either received no secondary challenge 
or were injected intraperitoneally with a DNP-carrier conjugate as indicated above. 
:~ The data are expressed as geometric means of serum anti-DNP antibody levels 8 days 
after secondary challenge of groups of six mice. A comparison of geometric mean antibody 
levels gave the following results: 
(a)  comparison of group A with group D yields 0.80  >  P  >  0.70, 
(b)  comparison of group C with group D yields 0.001  >  P, 
(c)  comparison of group E with group H yields 0.001  >  P, 
(d)  comparison of group G with group H  yields 0.001 >  P, 
(e)  comparison of group B with group F  yields 0.40  >  P  >  0.30, 
(f)  comparison of group C with group G yields 0.30  >  P  >  0.20. 
The  present  study  was  performed  to  determine  whether  or not  the  same  cir- 
cumstances  condition the phenomenon in mice. 
DNP-primed  spleen cells from BALB/c donor  mice, which had  been  primed  intraperi- 
toneally 2 wk earlier with 100 ~g of DNP-KLH in complete Freund's adjuvant, were injected 
intraperitoneally  into  groups  of  irradiated  syngeneic  or  allogeneie  (A  strain)  recipients. 
Individual mice received 25 X  106 primed spleen cells from a common single cell suspension 
pool.  Immediately after  cell transfer,  groups  of recipients were challenged with  either the 
homologous conjugate, DNP-KLH, or 50 #g of DNP-B GG. Control mice received no secondary 
challenge. 
The results, summarized in Table V, illustrate two important points: first, no 
allogeneic effect was  obtained  under  these  circumstances  as  evidenced by  the 450  ALLOGENEIC  EFFECT  IN  MICE 
failure to induce antibody production with DNP-BGG in the irradiated allo- 
geneic recipients of primed cells. As expected, no secondary response to DNP- 
BGG was obtained in the syngeneic combination in contrast to the very, brisk 
anamnestic response elicited by DNP-KLH. The second point of note was the 
slightly depressed antibody responses to DNP-KLH observed in the allogeneic 
combination. We do not place any importance on this, however, since the dif- 
ferences were not statistically significant. 
It would appear  from  this study, in  conjunction with the other  evidence 
cited above, that the primed B  cell must be more intimately involved in the 
allogeneic  cell  interaction in  order  for  a  demonstrable stimulatory effect on 
antibody production to occur. Clearly, a mere bystander status to the active 
cell interaction is not sufficient) 
DISCUSSION 
Since  the  breakthrough  observations  of  Claman  et  al.  (9)  which  demon- 
strated the requirement for cooperative interaction between T  and B lympho- 
cytes in development of humoral immune responses, delineation of the mecha- 
nism  of  this  interaction has  been  the  subject  of intense  investigation  (for 
review, see reference 10). The demonstration that induction of a transient graft- 
versus-host reaction can, under appropriate  circumstances, markedly enhance 
specific antibody production in a previously primed animal (1) has provided a 
useful model with which to approach this problem. Thus, the allogeneic effect, 
whose properties are discussed briefly in the introduction, and studies of other 
investigators using somewhat different systems (11,  12), have provided strong 
evidence for a hypothesis which considers T  cell regulation of B  cell function 
to be mediated through release of a soluble nonspecific factor(s)  from appro- 
priately activated T lymphocytes (10). 
The  present  studies  were  undertaken  to  establish  the  optimal  conditions 
for demonstrating the allogeneic effect in inbred mice. Although such details 
have been previously determined in inbred guinea pigs (1, 3), it seemed possible, 
if not likely, that certain critical factors might differ considerably from species 
to  species.  Moreover,  establishment of  this  phenomenon in  mice  offers the 
great  advantage of pursuing  the model in  the species  in which  the  most is 
known  about identifying and  separating  distinct T  and B  cell  populations. 
We have  shown that the  transfer of immunocompetent allogeneic lymphoid 
cells into recipient mice that were previously primed with DNP-KLH permits 
the  development of enhanced secondary anti-DNP  antibody responses  to  a 
2 It should be pointed out that the variation in magnitude of anti-DNP responses that is 
evident in the data tables herein reflect the varying extent to which mice were initially primed 
from one experiment to the next, i.e. in experiments where mice were better primed (as evi- 
denced by  higher day 0  antibody levels), the  magnitude of  the secondary responses was 
greatest. However, since each exl~eriment was internally controlled, the validity of interpreta- 
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DNP-conjugate  of an unrelated  carrier molecule. The  capacity to  elicit  this 
effect is determined by several critical experimental factors. 
One such factor appears to be the route of administration of allogeneic cells. 
Thus, DNP-KLH-primed CAF1 recipients of parental A strain lymphoid cells 
manifested better enhanced secondary anti-DNP responses to the optimal dose 
of DNP-BGG when 25  >(  106 allogeneic cells were injected intravenously than 
when the same number of allogeneic cells were administered intraperitoneally 
6 days before secondary challenge. In another experiment presented herein, a 
very striking allogeneic effect on the secondary response to 50 #g of DNP-BGG 
was  obtained in  such  mice  after intraperitoneal  transfer of 25  or 50  X  106 
allogeneic cells.  Nonetheless,  additional  studies  have generally confirmed the 
greater efficacy of the intravenous route when CAFI mice are used as recipients 
of parental donor cells.  In the case of DNP-KLH-primed BALB/c recipients 
of  allogeneic lymphoid  cells,  the  effect on  the  response  to  DNP-BGG  chal- 
lenge 6 days later was obtained only when the intravenous route was employed; 
transfer of cells intraperitoneally, in the doses used, failed to enhance anti-DNP 
antibody production. 
The magnitude of the allogeneic effect was  also related to  the numbers of 
donor  cells  transferred.  In  DNP-KLH-primed  CAF1  recipients  of intraperi- 
toneally  administered  A  strain  donor  cells,  secondary  anti-DNP  responses 
were considerably greater when 50 X  106 cells were give than when 25  X  106 
cells were  transferred 6  days before challenge with 50 #g of DNP-BGG. In 
the case of intravenously transferred allogeneic cells,  25  X  106 cells were con- 
siderably more effective than 5 X  106 cells in both CAF1 and BALB/c recipients. 
It appears,  moreover, that when the intravenous route is used,  more careful 
attention to cell dose is required. Thus, doses of allogeneic cells above 25 X  106 
per  recipient,  when  injected  intravenously,  have  generally  resulted  in  sup- 
pression  of  anti-DNP  antibody  production  (unpublished  observations).  Al- 
though the precise explanation for this latter point has not yet been defined, 
two possibilities  appear most likely:  (a)  the  GVH reaction, occurring in  the 
appropriate strength in lymphoid organs of the host, diminishes the number of 
DNP-primed  precursor  B  cells  available  to  respond  to  secondary antigenic 
stimulation. This may result either because such B  cells have been among the 
targets of specific action by T  lymphocytes of the donor population, or because 
they fall victim to nonspecific cytotoxic factors produced during such reactions. 
The  fact  that  large  numbers  of  cells  (100-200  X  106) administered  intra- 
venously across a  strong H-2  barrier (H-2  b ~  H-2  d)  results  in a  marked de- 
pression  in  the  secondary  anti-DNP  response  to  the  original  priming  DNP 
conjugate (unpublished observations) may support this notion. (b) A vigorous 
GVH reaction may result in the release of factors in quantitatively sufficient 
amounts to suppress nonspecifically certain parameters of B  cell function. In 
earlier experiments in  guinea pigs,  it was found that  at  certain times during 452  ALLOGENEIC  EFFECT  IN  MICE 
the course of the GVH reaction, one parameter of B cell function (i.e.  antibody 
production)  was  suppressed  while  induction  of  DNP-specific  memory,  re- 
flected  in  the  response  to  an  antigenic  challenge  made  at  a  later  time,  was 
significantly increased  (3).  These  two possibilities  are  not  nmtually  exclusive 
and, indeed, may both operate depending on the existing circumstances (3a). 
Another  relevant  factor  in  the  elicitation  of  the  allogeneic  effect in  mice, 
shown by these experiments, is the time interval employed between cell transfer 
and  secondary  challenge.  When  the  allogeneic  cells  are  transferred  intraven- 
ously, the magnitude of enhancement of anti-DNP responses was optimal when 
secondary antigen challenge was administered 2 days after cell transfer. In the 
case  of  secondary  responses  to  DNP-BGG,  enhancement  was  also  observed 
at intervals of 1, 3, and 6 days but  at a level of three- to fourfold less than that 
obtained  at  2  days.  Moreover,  the  secondary  responses  to  the  homologous 
antigen, DNP-KLH, which were generally not affected when intervals of 1, 3, 
or  6  days  were  employed,  were  considerably  increased  when  challenge  was 
made 2 days after cell  transfer. These observations differ from those made in 
guinea pigs where the 6 day" interval was clearly optimal (1). It is quite possible, 
however,  that  the  optimal time interval in  mice ma\" differ according  to  the 
strength  of the  histocompatibility differences between donor  and  host  strains 
being  studied. 
Perhaps  the  most intriguing  aspect of the  allogeneic effect is  the  apparent 
obviation of the requirement for participation of carrier-specific helper T  cells 
in the development of DNP-specific secondary' responses (1-3). This has been 
confirmed in  the  present  studies  in  mice in  which  a  secondary anti-DNP  re- 
sponse  was  obtained  in  animals  undergoing  a  GVH  reaction  after  challenge 
with DNP-D-GL. This particular DNP conjugate is not only nonimmunogenic 
but  also  induces  a  profound  state  of  DNP-specific  tolerance  when  admin- 
istered under  normal conditions  to  guinea pigs  (2)  or mice  (unpublished  ob- 
servations).  It  is  presumed,  and  some  evidence  exists,  a  that  functional  T 
cells  with  specificity  for  D-GL  do  not  exist  in  these  animals.  The  capacity 
to  elicit  an  anti-DNP  antibody  response  with  DNP-D-GL  in  the  presence 
of a  GVH reaction provides,  therefore,  compelling evidence that,  indeed,  the 
allogeneic  effect  circumvents  the  required  participation  of  carrier-specific 
helper  cells  in  the  anti-hapten  antibody  response.  As  suggested  earlier  (2), 
it is not unlikely that this stimulation of antibody-forming cell precursors by a 
normally  nonimmunogenic  substance  during  the  allogeneic  effect  may  well 
have significant pathogenetic implications. It is conceivable, for example, that 
potent nonspecific stimuli of the immune system analogous to the GVH reac- 
tion,  such  as  might occur during  certain  infectious  processes, may stimulate 
the  development  of  autoantibodies  to  host  antigens  which  may be  tolerated 
3  Katz, D. H., W. E. Paul, and B. Benacerraf. 1972. Carrier function in anti-hapten anti- 
body responses, VI. Establishment of experimental conditions for either inhibitory or enhanc- 
ing influences of carrler-specific  cells on antibody production. Manuscript submitted. DAVID  P.  OSBORNE,  JR.  AND  DAVID  H.  KATZ  453 
as a result of unresponsiveness in the helper cell population. Under the influence 
of such potent stimuli, direct activation of precursors of antibody-forming cells 
by host antigens may occur. 
Finally,  the  demonstration  that  no  enhancement  of  the  secondary  anti- 
DNP response occurred after passive transfer of DNP-KLH-primed BALB/c 
spleen  cells  into  irradiated  allogeneic  recipients  bears  directly on  questions 
concerning the nature of the cellular interactions involved in this phenomenon. 
Thus,  although  a  presumably strong one-way allogeneic cell interaction  (i.e. 
the reaction of donor T  lymphocytes against histocompatibility antigens of the 
host,  but not vice versa)  existed,  the  response of primed B  lymphocytes, in 
this case members of the donor cell population, was not appreciably affected. 
Taken in context with similar observations reported previously in guinea pigs 
(1, 3), this finding suggests that the primed B  cell must be an integral partici- 
pant in the GVH reaction and not a mere bystander to the allogeneic cell inter- 
actions. Indeed, in the accompanying paper (4)  we provide proof of this point 
by  demonstrating  the  elicitation  of  the  allogeneic  effect on  primed  B  cells 
from which isologous T  cells have been depleted. 
SUMMARY 
The  administration  of allogeneic lymphoid  cells  to  2,4-dinitrophenyl key- 
hole  limpet  hemocyanin  (DNP-KLH)-primed  mice  prepares  such  recipients 
for markedly  enhanced  secondary  anti-DNP  antibody  responses  to  a  DNP 
conjugate of a heterologous carrier. This allogeneic effect phenomenon, reflecting 
the development of a  graft-versus-host  (GVH)  reaction, was first described in 
guinea pigs and has been extended in the present studies to inbred mice. The 
expression of  the  allogeneic effect in  mice is  dependent upon  critical factors 
such  as  the number and  route of administration  of allogeneic cells,  the  time 
interval  between  cell  transfer  and  secondary challenge,  and  the  strength  of 
histocompatibility differences between the donor and  the host.  The transient 
GVH reaction established  by the  transfer of allogeneic cells  obviates the re- 
quirement for carrier-specific helper T  cells in secondary anti-DNP responses, 
as evidenced by the ability to elicit such responses with DNP-D-GL, a substance 
which presumably does not stimulate  effective T  cell  helper function. These 
studies  also demonstrate  that primed B  cells which  are  not an integral  part 
of the active GVH reaction fail to produce enhanced levels of antibody'. 
The  authors  are  deeply  indebted  to  Professor Baruj  Benacerraf  for  his  advice  and  en- 
couragement during  the course  of  these studies.  We  thank  Mr.  Herbert  Levine for  expert 
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tion of the manuscript. 
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